跳至主要内容
临床试验/CTRI/2023/08/057147
CTRI/2023/08/057147尚未招募3 期

The role of glutamine in prevention of chemotherapy- induced peripheral neuropathy in breast cancer patients - NI

Jawaharlal Nehru Medical College Aligarh Muslim University Aligarh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Breast cancer diagnosed patients who are advised chemotherapy
  • Patients willing to participate after informed consent
  • Age 18 years and above
  • Normal performance status (ECOG 2)
  • Adequate renal and liver function
  • No co- morbidities

排除标准

  • Hypothyroidism or hyperthyroidism
  • Diabetes mellitus
  • Previously diagnosed neuropathy
  • Pre existing autoimmune disease
  • Anti tubercular OR Anti viral therapy
  • Congestive heart failure, liver failure or renal failure
  • Chronic anemia
  • Chronic alcoholism, chronic smoking or drug abuse
  • Previously chemotherapy received

研究者

发起方
Jawaharlal Nehru Medical College Aligarh Muslim University Aligarh

相似试验

erve conduction studies changes in breast cancer... | 临床试验